How is the Drugs for Immunotherapy Market Poised for Growth: Trends and Opportunities Through 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the drugs for immunotherapy market right now?
The immunotherapy drugs market has seen a significant expansion in size over the past few years. The market, which is set to balloon from $255.14 billion in 2024 to $281.43 billion in 2025, is expected to see a compound annual growth rate (CAGR) of 10.3%. Factors such as an increased prevalence of cancer, uncatered medical requirements, heightened awareness about cancer immunotherapy, attractive adoption rates of immunotherapy techniques, and increased investments from major pharmaceutical entities have contributed to the surge in the growth rate registered in the past years.
How fast Is the drugs for immunotherapy market expected to grow, and what’s its future value?
The immunotherapy drugs market is projected to witness swift expansion in the ensuing years, escalating to a remarkable $445.12 billion by 2029, with a 12.1% Compound Annual Growth Rate (CAGR). This growth within the forecasted period could be credited to factors such as the proliferation of combination treatments, customization in medicine, worldwide expansion, biomarker-guided therapies, and a rise in clinical trials. The major impending trends include advancements in the realm of immunology, car-t cell therapies, targeted immunotherapies, combinations of immunotherapy, and the development of neoantigen vaccines.
Get your drugs for immunotherapy market report here!
https://www.thebusinessresearchcompany.com/sample.aspx?id=2559&type=smp
What are the leading drivers of growth in the drugs for immunotherapy market?
The market for immunotherapy drugs is propelled by an increasing number of cancer cases worldwide. A few of the most common cancer origins are obesity, smoking, alcohol consumption, and unhealthy eating. For example, Macmillan Cancer Support, the UK’s top health charity, estimates that by 2025 there will be 3.5 million cancer sufferers, 4 million by 2030, and 5.3 million by 2040. The most common types of cancers are those of the breast, lung, colon, rectum, and prostate. About one third of cancer deaths can be attributed to the use of tobacco, high body mass index, alcohol consumption, a diet low in fruits and vegetables, and a lack of exercise. It’s predicted that as cancer cases continue to rise, so will the demand for immunotherapy drugs, subsequently giving a boost to the growth of the immunotherapy drugs market.
What are the key segments defining the drugs for immunotherapy market?
The drugs for immunotherapy market covered in this report is segmented –
1) By Type: Monoclonal Antibodies, Interferons, Interleukins, Vaccines, Checkpoint Inhibitors, Other Types
2) By Therapy Area: Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases, Other Therapy Areas
3) By End User: Hospitals & Clinics, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Monoclonal Antibodies: Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bispecific Monoclonal Antibodies
2) By Interferons: Interferon Alfa, Interferon Beta, Interferon Gamma
3) By Interleukins: Interleukin-2 (IL-2), Interleukin-6 (IL-6), Interleukin-12 (IL-12)
4) By Vaccines: Preventive Vaccines, Therapeutic Vaccines
5) By Checkpoint Inhibitors: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors
6) By Other Types: Cancer Cell Therapies, Cytokine Therapy, T-Cell Receptor Therapy
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2559&type=smp
Who are the key players steering the development of the drugs for immunotherapy market?
Major companies operating in the drugs for immunotherapy market include F. Hoffmann-La Roche Ltd., Novartis AG, Amgen Inc., AbbVie Inc., Merck & Co. Inc., GlaxoSmithKline plc, Eli Lilly and Company, Bristol-Myers Squibb, AstraZeneca plc, Johnson & Johnson, UbiVac, Pfizer Inc., Sanofi SA, Bayer AG, Celgene Corporation, Incyte Corporation, Juno Therapeutics Inc., Bluebird bio, Celldex Therapeutics, BeiGene, BioNTech AG, CytomX Therapeutics, Eisai Co. Ltd., Flexus Biosciences Inc., Genscript Biotech Corporation, Gilead Sciences Inc., Harpoon Therapeutics Inc., Heptares Therapeutics Ltd., Ignyta Inc., Immatics Biotechnologies, Jounce Therapeutics Inc.
What emerging trends are influencing the growth of the drugs for immunotherapy market?
Major corporations in the immunotherapy drugs market are concentrating their efforts on developing new products like Keytruda (pembrolizumab) to better serve their clients. Keytruda (pembrolizumab) is a unique form of immunotherapy that uses an immune checkpoint inhibitor medication designed for adult patients. For example, Merck & Co., Inc., a pharmaceutical company based in the US, introduced Keytruda (pembrolizumab) in January 2023. This product, which was sanctioned by the US-based federal agency, the Food and Drug Administration, is used in the treatment of various cancers by collaborating with the immune system to battle cancer cells. As an adjuvant therapy for non-small cell lung cancer (NSCLC), KEYTRUDA (pembrolizumab) has been approved. This advancement in cancer care is significant and is predicted to positively influence the healthcare industry.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2559
Which regions are most influential in expanding the drugs for immunotherapy market?
North America was the largest region in the immunotherapy market in 2024. Middle East is expected to be the fastest growing region in the drug for immunotherapy market report during the forecast period. The regions covered in the drugs for immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Browse Through More Similar Reports By The Business Research Company:
Cellular Immunotherapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report
Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2024
Immunofluorescence Assay Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
